{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antioxidant", "benzimidazole-ureas", "diabetes mellitus", "enzyme inhibition", "isocyanates", "molecular docking simulation"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36839780", "DateRevised": {"Year": "2023", "Month": "03", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "01", "Day": "30"}], "Language": ["eng"], "ELocationID": ["457", "10.3390/pharmaceutics15020457"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "15", "Issue": "2", "PubDate": {"Year": "2023", "Month": "Jan", "Day": "30"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Synthesis, Molecular Docking, and Bioactivity Study of Novel Hybrid Benzimidazole Urea Derivatives: A Promising \u03b1-Amylase and \u03b1-Glucosidase Inhibitor Candidate with Antioxidant Activity.", "Abstract": {"AbstractText": ["A novel series of benzimidazole ureas <b>3a-h</b> were elaborated using 2-(1<i>H</i>-benzoimidazol-2-yl) aniline <b>1</b> and the appropriate isocyanates <b>2a-h</b>. The antioxidant and possible antidiabetic activities of the target benzimidazole-ureas <b>3a-h</b> were evaluated. Almost all compounds <b>3a-h</b> displayed strong to moderate antioxidant activities. When tested using the three antioxidant techniques, TAC, FRAP, and MCA, compounds <b>3b</b> and <b>3c</b> exhibited marked activity. The most active antioxidant compound in this family was compound <b>3g</b>, which had excellent activity using four different methods: TAC, FRAP, DPPH-SA, and MCA. In vitro antidiabetic assays against \u03b1-amylase and \u03b1-glucosidase enzymes revealed that the majority of the compounds tested had good to moderate activity. The most favorable results were obtained with compounds <b>3c</b>, <b>3e</b>, and <b>3g</b>, and analysis revealed that compounds <b>3c</b> (IC<sub>50</sub> = 18.65 \u00b1 0.23 \u03bcM), <b>3e</b> (IC<sub>50</sub> = 20.7 \u00b1 0.06 \u03bcM), and <b>3g</b> (IC<sub>50</sub> = 22.33 \u00b1 0.12 \u03bcM) had good \u03b1-amylase inhibitory potential comparable to standard acarbose (IC<sub>50</sub> = 14.21 \u00b1 0.06 \u03bcM). Furthermore, the inhibitory effect of <b>3c</b> (IC<sub>50</sub> = 17.47 \u00b1 0.03 \u03bcM), <b>3e</b> (IC<sub>50</sub> = 21.97 \u00b1 0.19 \u03bcM), and <b>3g</b> (IC<sub>50</sub> = 23.01 \u00b1 0.12 \u03bcM) on \u03b1-glucosidase was also comparable to acarbose (IC<sub>50</sub> = 15.41 \u00b1 0.32 \u03bcM). According to in silico molecular docking studies, compounds <b>3a-h</b> had considerable affinity for the active sites of human lysosomal acid \u03b1-glucosidase (HLAG) and pancreatic \u03b1-amylase (HPA), indicating that the majority of the examined compounds had potential anti-hyperglycemic action."]}, "AuthorList": [{"Identifier": ["0000-0002-4471-6137"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, College of Science, Qassim University, Qassim Main Campus, King Abdulaziz Road, P.O. Box 6644, Al-Malida, Buraydah 51452, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Laboratory of Structural Organic Chemistry-Synthesis and Physicochemical Studies (LR99ES14), Department of Chemistry, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis 2092, Tunisia."}, {"Identifier": [], "Affiliation": "Faculty of Sciences of Bizerte, Carthage University, Jarzouna, Bizerte 7021, Tunisia."}], "LastName": "Aroua", "ForeName": "Lotfi M", "Initials": "LM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, College of Science, Qassim University, Qassim Main Campus, King Abdulaziz Road, P.O. Box 6644, Al-Malida, Buraydah 51452, Saudi Arabia."}], "LastName": "Alosaimi", "ForeName": "Abdulelah H", "Initials": "AH"}, {"Identifier": ["0000-0002-3649-0190"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, College of Science, Qassim University, Qassim Main Campus, King Abdulaziz Road, P.O. Box 6644, Al-Malida, Buraydah 51452, Saudi Arabia."}], "LastName": "Alminderej", "ForeName": "Fahad M", "Initials": "FM"}, {"Identifier": ["0000-0003-0485-4997"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, College of Science, Qassim University, Qassim Main Campus, King Abdulaziz Road, P.O. Box 6644, Al-Malida, Buraydah 51452, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Faculty of Sciences of Bizerte, Carthage University, Jarzouna, Bizerte 7021, Tunisia."}], "LastName": "Messaoudi", "ForeName": "Sabri", "Initials": "S"}, {"Identifier": ["0000-0003-2896-6790"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraidah 51452, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy, Al-Azhar University, Cairo 11371, Egypt."}], "LastName": "Mohammed", "ForeName": "Hamdoon A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraidah 51452, Saudi Arabia."}], "LastName": "Almahmoud", "ForeName": "Suliman A", "Initials": "SA"}, {"Identifier": ["0000-0002-1081-2964"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraidah 51452, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Saveetha Nagar, Thandalam, Chennai 602105, India."}], "LastName": "Chigurupati", "ForeName": "Sridevi", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, College of Science, Qassim University, Qassim Main Campus, King Abdulaziz Road, P.O. Box 6644, Al-Malida, Buraydah 51452, Saudi Arabia."}], "LastName": "Albadri", "ForeName": "Abuzar E A E", "Initials": "AEAE"}, {"Identifier": ["0000-0003-2924-3551"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Structural Organic Chemistry-Synthesis and Physicochemical Studies (LR99ES14), Department of Chemistry, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis 2092, Tunisia."}, {"Identifier": [], "Affiliation": "High Institute of Medical Technologies of Tunis, El Manar University, Tunis 1006, Tunisia."}], "LastName": "Mekni", "ForeName": "Nejib H", "Initials": "NH"}], "GrantList": [{"GrantID": "QU-IF-4-5-4-31680", "Agency": "Deputyship for Research& Innovation, Ministry of Education, Saudi Arabia", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Shahidpour S., Panahi F., Yousefi R., Nourisefat M., Nabipoor M., Khalafi-Nezhad A. Design and synthesis of new antidiabetic \u03b1-glucosidase and \u03b1-amylase inhibitors based on pyrimidine-fused heterocycles. Med. Chem. Res. 2015;24:3086\u20133096. doi: 10.1007/s00044-015-1356-2.", "ArticleIdList": ["10.1007/s00044-015-1356-2"]}, {"Citation": "Cheng H.C., Chang T.K., Su W.C., Tsai H.L., Wang J.Y. Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes. Transl. Oncol. 2021;14:101089. doi: 10.1016/j.tranon.2021.101089.", "ArticleIdList": ["10.1016/j.tranon.2021.101089", "PMC8058559", "33838541"]}, {"Citation": "Ozougwu J., Obimba K., Belonwu C., Unakalamba K. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J. Physiol. Pathophysiol. 2013;4:46\u201357. doi: 10.5897/JPAP2013.0001.", "ArticleIdList": ["10.5897/JPAP2013.0001"]}, {"Citation": "Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res. Clin. Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843.", "ArticleIdList": ["10.1016/j.diabres.2019.107843", "31518657"]}, {"Citation": "Al-Omar M.S., Mohammed H.A., Mohammed S.A.A., Abd-Elmoniem E., Kandil Y.I., Eldeeb H.M., Chigurupati S., Sulaiman G.M., Al-Khurayyif H.K., Almansour B.S. Anti-Microbial, Anti-Oxidant, and \u03b1-Amylase Inhibitory Activity of Traditionally-Used Medicinal Herbs: A Comparative Analyses of Pharmacology, and Phytoconstituents of Regional Halophytic Plants\u2019 Diaspora. Molecules. 2020;25:5457. doi: 10.3390/molecules25225457.", "ArticleIdList": ["10.3390/molecules25225457", "PMC7699972", "33233786"]}, {"Citation": "Mani V., Arfeen M., Mohammed H.A., Elsisi H.A., Sajid S., Almogbel Y., Aldubayan M., Dhanasekaran M., Alhowail A. Sukkari Dates Seed Improves Type-2 Diabetes Mellitus-Induced Memory Impairment by Reducing Blood Glucose Levels and Enhancing Brain Cholinergic Transmission: In Vivo and Molecular Modeling Studies. Saudi Pharm. J. 2022;30:750\u2013763. doi: 10.1016/j.jsps.2022.03.016.", "ArticleIdList": ["10.1016/j.jsps.2022.03.016", "PMC9257867", "35812141"]}, {"Citation": "Asgari M.S., Mohammadi-Khanaposhtani M., Kiani M., Ranjbar P.R., Zabihi E., Pourbagher R., Larijani B. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro \u03b1-glucosidase inhibition, kinetic, and docking studies. Bioorg. Chem. 2019;92:103206. doi: 10.1016/j.bioorg.2019.103206.", "ArticleIdList": ["10.1016/j.bioorg.2019.103206", "31445191"]}, {"Citation": "Piconi L., Quagliaro L., Ceriello A. Oxidative stress in diabetes. Clin. Chem. Lab. Med. 2003;41:1144\u20131149. doi: 10.1515/CCLM.2003.177.", "ArticleIdList": ["10.1515/CCLM.2003.177", "14598863"]}, {"Citation": "Oberley L.W. Free radicals and diabetes. Free Radic. Biol. Med. 1988;5:113\u2013124. doi: 10.1016/0891-5849(88)90036-6.", "ArticleIdList": ["10.1016/0891-5849(88)90036-6", "3075947"]}, {"Citation": "Sun C., Liu Y., Zhan L., Rayat G.R., Xiao J., Jiang H., Li X., Chen K. Anti-diabetic effects of natural antioxidants from fruits. Trends Food Sci. Technol. 2021;117:3\u201314. doi: 10.1016/j.tifs.2020.07.024.", "ArticleIdList": ["10.1016/j.tifs.2020.07.024"]}, {"Citation": "Amin E., Abdel-Bakky M.S., Darwish M.A., Mohammed H.A., Chigurupati S., Qureshi K.A., Hassan M.H.A. The Glycemic Control Potential of Some Amaranthaceae Plants, with Particular Reference to In Vivo Antidiabetic Potential of Agathophora alopecuroides. Molecules. 2022;27:973. doi: 10.3390/molecules27030973.", "ArticleIdList": ["10.3390/molecules27030973", "PMC8839903", "35164238"]}, {"Citation": "Yorek M.A. The role of oxidative stress in diabetic vascular and neural disease. Free Radic. Res. 2003;37:471\u2013480. doi: 10.1080/1071576031000083161.", "ArticleIdList": ["10.1080/1071576031000083161", "12797466"]}, {"Citation": "Morcoss M.M., El Shimaa M.N., Ibrahem R.A., Abdel-Rahman H.M., Abdel-Aziz M., Abou El-Ella D.A. Design, Synthesis, Mechanistic Studies and In Silico ADME predictions of Benzimidazole derivatives as Novel Antifungal Agents. Bioorg. Chem. 2020;22:103956. doi: 10.1016/j.bioorg.2020.103956.", "ArticleIdList": ["10.1016/j.bioorg.2020.103956", "32512267"]}, {"Citation": "Patel V.M., Patel N.B., Chan-Bacab M.J., Rivera G. N-Mannich bases of benzimidazole as a potent antitubercular and antiprotozoal agents: Their synthesis and computational studies. Synth. Commun. 2020;50:858\u2013878. doi: 10.1080/00397911.2020.1725057.", "ArticleIdList": ["10.1080/00397911.2020.1725057"]}, {"Citation": "Onajole O.K., Lun S., Yun Y.J., Langue D.Y., Jaskula-Dybka M., Flores A., Frazier E., Scurry A.C., Zavala A., Arreola K.R., et al. Design, Synthesis and biological evaluation of novel imidazo [1,2-a] pyridinecarboxamides as potent anti-tuberculosis agents. Chem. Biol. Drug Des. 2020;96:1362\u20131371. doi: 10.1111/cbdd.13739.", "ArticleIdList": ["10.1111/cbdd.13739", "PMC8720286", "32515129"]}, {"Citation": "Ganie A.M., Dar A.M., Khan F.A., Dar B.A. Benzimidazole derivatives as potential antimicrobial and antiulcer agents: A mini review. Mini Rev. Med. Chem. 2019;19:1292\u20131297. doi: 10.2174/1381612824666181017102930.", "ArticleIdList": ["10.2174/1381612824666181017102930", "30332950"]}, {"Citation": "Tonelli M., Gabriele E., Piazza F., Basilico N., Parapini S., Tasso B., Loddo R., Sparatore F., Sparatore A. Benzimidazole derivatives endowed with potent antileishmanial activity. J. Enzym. Inhib. Med. Chem. 2018;33:210\u2013226. doi: 10.1080/14756366.2017.1410480.", "ArticleIdList": ["10.1080/14756366.2017.1410480", "PMC7011974", "29233048"]}, {"Citation": "Taha M., Mosaddik A., Rahim F., Ali S., Ibrahim M., Almandil N.B. Synthesis, antiglycation and antioxidant potentials of benzimidazole derivatives. J. King Saud Univ. Sci. 2020;32:191\u2013194. doi: 10.1016/j.jksus.2018.04.003.", "ArticleIdList": ["10.1016/j.jksus.2018.04.003"]}, {"Citation": "Sirim M.M., Krishna V.S., Sriram D., Tan O.U. Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity. Eur. J. Med. Chem. 2020;188:112010. doi: 10.1016/j.ejmech.2019.112010.", "ArticleIdList": ["10.1016/j.ejmech.2019.112010", "31893548"]}, {"Citation": "Pan T., He X., Chen B., Chen H., Geng G., Luo H., Zhang H., Bai C. Development of benzimidazole derivatives to inhibit HIV-1 replication through protecting APOBEC3G protein. Eur. J. Med. Chem. 2015;95:500\u2013513. doi: 10.1016/j.ejmech.2015.03.050.", "ArticleIdList": ["10.1016/j.ejmech.2015.03.050", "25847768"]}, {"Citation": "Zhang X., Zhang C., Tang L., Lu K., Zhao H., Wu W., Jiang Y. Synthesis and biological evaluation of piperidyl benzimidazole carboxamide derivatives as potent PARP-1 inhibitors and antitumor agents. Chin. Chem. Lett. 2020;31:136\u2013140. doi: 10.1016/j.cclet.2019.04.045.", "ArticleIdList": ["10.1016/j.cclet.2019.04.045"]}, {"Citation": "Ashok D., Reddy M.R., Nagaraju N., Dharavath R., Ramakrishna K., Gundu S., Shravani P., Sarasija M. Microwave-assisted synthesis and in vitro antiproliferative activity of some novel 1,2,3-triazole-based pyrazole aldehydes and their benzimidazole derivatives. Med. Chem. Res. 2020;29:699\u2013706. doi: 10.1007/s00044-020-02515-6.", "ArticleIdList": ["10.1007/s00044-020-02515-6"]}, {"Citation": "Sharma S., Kumar D., Singh G., Monga V., Kumar B. Recent advancements in the development of heterocyclic anti-inflammatory agents. Eur. J. Med. Chem. 2020;16:112438. doi: 10.1016/j.ejmech.2020.112438.", "ArticleIdList": ["10.1016/j.ejmech.2020.112438", "32485533"]}, {"Citation": "Achar K.C., Hosamani K.M., Seetharamareddy H.R. In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives. Eur. J. Med. Chem. 2010;45:2048\u20132054. doi: 10.1016/j.ejmech.2010.01.029.", "ArticleIdList": ["10.1016/j.ejmech.2010.01.029", "20133024"]}, {"Citation": "Francesconi V., Cichero E., Schenone S., Naesens L., Tonelli M. Synthesis and Biological Evaluation of Novel (thio) semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses. Molecules. 2020;25:1487. doi: 10.3390/molecules25071487.", "ArticleIdList": ["10.3390/molecules25071487", "PMC7180491", "32218301"]}, {"Citation": "Mavrova A.T., Anichina K.K., Vuchev D.I., Tsenov J.A., Denkova P.S., Kondeva M.S., Micheva M.K. Antihelminthic activity of some newly synthesized 5 (6)-(un)substituted-1H-benzimidazol-2-ylthioacetylpiperazine derivatives. Eur. J. Med. Chem. 2006;41:1412\u20131420. doi: 10.1016/j.ejmech.2006.07.005.", "ArticleIdList": ["10.1016/j.ejmech.2006.07.005", "16996654"]}, {"Citation": "Hori A., Imaeda Y., Kubo K., Kusaka M. Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis in vitro and in vivo. Cancer Lett. 2002;183:53. doi: 10.1016/S0304-3835(02)00110-6.", "ArticleIdList": ["10.1016/S0304-3835(02)00110-6", "12049814"]}, {"Citation": "Abdel-Mohsen H.T., Ragab F.A.F., Ramla M.M., El Diwani H.I. Novel benzimidazole-pyrimidine conjugates as potent antitumor agents. Eur. J. Med. Chem. 2010;45:2336. doi: 10.1016/j.ejmech.2010.02.011.", "ArticleIdList": ["10.1016/j.ejmech.2010.02.011", "20356655"]}, {"Citation": "Velaparthi U., Liu P., Balasubramanian B., Carboni J., Attar R., Gottardis M., Li A., Greer A., Zoeckler M., Wittman M.D., et al. Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile. Med. Chem. Lett. 2007;17:3072. doi: 10.1016/j.bmcl.2007.03.048.", "ArticleIdList": ["10.1016/j.bmcl.2007.03.048", "17398093"]}, {"Citation": "Pagano M.A., Andrzejewska M., Ruzzene M., Sarno S., Cesaro L., Bain J., Elliott M., Meggio F., Kazimierczuk Z., Pinna L.A. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole. J. Med. Chem. 2004;47:6239. doi: 10.1021/jm049854a.", "ArticleIdList": ["10.1021/jm049854a", "15566294"]}, {"Citation": "Neff D.K., LeeDutra A., Blevitt J.M., Axe F.U., Hack M.D., Buma J.C., Rynberg R., Brunmark A., Karlsson L., Breitenbucher G. 2-Aryl benzimidazoles featuring alkyl-linked pendant alcohols and amines as inhibitors of checkpoint kinase Chk2. Bioorg. Med. Chem. Lett. 2007;17:6467. doi: 10.1016/j.bmcl.2007.09.098.", "ArticleIdList": ["10.1016/j.bmcl.2007.09.098", "17937984"]}, {"Citation": "Arienti K.L., Brunmark A., Axe F.U., McClure K., Lee A., Blevitt J., Neff D.K., Huang L., Crawford S., Pandit C.R., et al. Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles. J. Med. Chem. 2005;48:1873. doi: 10.1021/jm0495935.", "ArticleIdList": ["10.1021/jm0495935", "15771432"]}, {"Citation": "Hajduk J.P., Boyd S., Nettesheim D., Nienaber V., Severin J., Smith R., Davidson D., Rockway T., Fesik S.W. Identification of novel inhibitors of urokinase via NMR-based screening. J. Med. Chem. 2000;43:3862\u20133866. doi: 10.1021/jm0002228.", "ArticleIdList": ["10.1021/jm0002228", "11052791"]}, {"Citation": "Hussain S., Taha M., Rahim F., Hayat S., Zaman K., Iqbal N., Selvaraj M., Sajid M., Bangesh M.A., Khan F., et al. Synthesis of benzimidazole derivatives as potent inhibitors for \u03b1-amylase and their molecular docking study in management of type-II diabetes. J. Mol. Struct. 2021;1232:130029. doi: 10.1016/j.molstruc.2021.130029.", "ArticleIdList": ["10.1016/j.molstruc.2021.130029"]}, {"Citation": "Liu Z., Ma S. Recent Advances in Synthetic \u03b1-Glucosidase Inhibitors. ChemMedChem. 2017;12:819\u2013829. doi: 10.1002/cmdc.201700216.", "ArticleIdList": ["10.1002/cmdc.201700216", "28498640"]}, {"Citation": "Ullah H., Ullah H., Taha M., Khan F., Rahim F., Uddin I., Sarfraz M., Ali Shah S.A., Aziz A., Mubeen S. Synthesis, In Vitro \u03b1-Amylase Activity, and Molecular Docking Study of New Benzimidazole Derivatives. Russ. J. Org. Chem. 2021;57:968\u2013975. doi: 10.1134/S1070428021060130.", "ArticleIdList": ["10.1134/S1070428021060130"]}, {"Citation": "Cakmak U., Oz-Tuncay F., Basoglu-Ozdemir S., Ayazoglu-Demir E., Demir I., Colak A., Celik-Uzuner S., Erdem S.S., Yildirim N. Synthesis of hydrazine containing piperazine or benzimidazole derivatives and their potential as \u03b1-amylase inhibitors by molecular docking, inhibition kinetics and in vitro cytotoxicity activity studies. Med. Chem. Res. 2021;30:1886\u20131904. doi: 10.1007/s00044-021-02785-8.", "ArticleIdList": ["10.1007/s00044-021-02785-8"]}, {"Citation": "Khan S., Ullah H., Rahim F., Nawaz M., Hussain R., Rasheed L. Synthesis, in vitro \u03b1-Amylase, \u03b1-Glucosidase Activities and Molecular Docking Study of New Benzimidazole Bearing Thiazolidinone Derivatives. J. Mol. Struct. 2022;1269:133812. doi: 10.1016/j.molstruc.2022.133812.", "ArticleIdList": ["10.1016/j.molstruc.2022.133812"]}, {"Citation": "Taha M., Imran S., Ismail N.H., Selvaraj M., Rahim F., Chigurupati S., Ullah H., Khan F., Salar U., Javid M.T., et al. Biology-oriented drug synthesis (BIODS) of 2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethyl aryl ether derivatives, in vitro \u03b1-amylase inhibitory activity and in silico studies. Bioorg. Chem. 2017;74:1\u20139. doi: 10.1016/j.bioorg.2017.07.001.", "ArticleIdList": ["10.1016/j.bioorg.2017.07.001", "28719801"]}, {"Citation": "Wang X., Ling N., Che Q.T., Zhang Y.W., Yang H.X., Ruan Y., Zhao T.T. Synthesis, structure and biological properties of benzimidazole-based Cu (II)/Zn (II) complexes. Inorg. Chem. Commun. 2019;105:97\u2013101. doi: 10.1016/j.inoche.2019.04.038.", "ArticleIdList": ["10.1016/j.inoche.2019.04.038"]}, {"Citation": "Sivaramakarthikeyan R., Iniyaval S., Saravanan V., Lim W.M., Mai C.W., Ramalingan C. Molecular Hybrids Integrated with Benzimidazole and Pyrazole Structural Motifs: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies. ACS Omega. 2020;5:10089\u201310098. doi: 10.1021/acsomega.0c00630.", "ArticleIdList": ["10.1021/acsomega.0c00630", "PMC7203960", "32391496"]}, {"Citation": "Arshad T., Khan K.M., Rasool N., Salar U., Hussain S., Asghar H., Ashraf M., Wadood A., Riaz M., Perveen S., et al. 5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of \u03b1-glucosidase and urease enzymes. Bioorg. Chem. 2017;72:21\u201331. doi: 10.1016/j.bioorg.2017.03.007.", "ArticleIdList": ["10.1016/j.bioorg.2017.03.007", "28346872"]}, {"Citation": "Ozil M., Parlak C., Baltas N.A. Simple and efficient synthesis of benzimidazoles containing piperazine or morpholine skeleton at C-6 position as glucosidase inhibitors with antioxidant activity. Bioorg. Chem. 2018;6:468\u2013477. doi: 10.1016/j.bioorg.2017.12.019.", "ArticleIdList": ["10.1016/j.bioorg.2017.12.019", "29287256"]}, {"Citation": "Taha M., Rahim F., Zaman K., Selvaraj M., Uddin N., Farooq R.K., Nawaz M., Sajid M., Nawaz F., Ibrahim M., et al. Synthesis, \u03b1-glycosidase inhibitory potential and molecular docking study of benzimidazole derivatives. Bioorg. Chem. 2020;95:103555. doi: 10.1016/j.bioorg.2019.103555.", "ArticleIdList": ["10.1016/j.bioorg.2019.103555", "31911306"]}, {"Citation": "Singh G., Singh A., Singh V., Verma R.K., Tomar J., Mall R. Synthesis, molecular docking, \u03b1-glucosidase inhibition, and antioxidant activity studies of novel benzimidazole derivatives. Med. Chem. Res. 2020;29:1846\u20131866. doi: 10.1007/s00044-020-02605-5.", "ArticleIdList": ["10.1007/s00044-020-02605-5"]}, {"Citation": "Rahim F., Zaman K., Taha M., Ullah H., Ghufran M., Wadood A., Rehman W., Uddin N., Shah S.A.A., Sajid M., et al. Synthesis, in vitro alphaglucosidase inhibitory potential of benzimidazole bearing bis-Schiff bases and their molecular docking study. Bioorg. Chem. 2020;94:103394. doi: 10.1016/j.bioorg.2019.103394.", "ArticleIdList": ["10.1016/j.bioorg.2019.103394", "31699396"]}, {"Citation": "Asemanipoor N., Mohammadi-Khanaposhtani M., Moradi S., Vahidi M., Asadi M., Faramarzi M.A., Mahdavi M., Biglar M., Larijani B., Hamedifar H., et al. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential \u03b1-glucosidase inhibitors. Bioorg. Chem. 2020;95:103482. doi: 10.1016/j.bioorg.2019.103482.", "ArticleIdList": ["10.1016/j.bioorg.2019.103482", "31838286"]}, {"Citation": "Bharadwaj S.S., Poojary B., Nandish S.K.M., Kengaiah J., Kirana M.P., Shankar M.K., Das A.J., Kulal A., Sannaningaiah D. Efficient synthesis and in silico studies of the benzimidazole hybrid scaffold with the quinolinyloxadiazole skeleton with potential \u03b1-glucosidase inhibitory, anticoagulant, and antiplatelet activities for type-II diabetes mellitus management and treating thrombotic disorders. ACS Omega. 2018;3:12562\u201312574. doi: 10.1021/acsomega.8b01476.", "ArticleIdList": ["10.1021/acsomega.8b01476", "PMC6217529", "30411010"]}, {"Citation": "Zawawi N.K.N.A., Taha M., Ahmat N., Ismail N.H., Wadood A., Rahim F. Synthesis, molecular docking studies of hybrid benzimidazole as \u03b1-glucosidase inhibitor. Bioorg. Chem. 2017;70:184\u2013191. doi: 10.1016/j.bioorg.2016.12.009.", "ArticleIdList": ["10.1016/j.bioorg.2016.12.009", "28043716"]}, {"Citation": "Mente\u015fe E., Baltas N., Emirik M. Synthesis, \u03b1-Glucosidase Inhibition and in Silico Studies of Some 4-(5-Fluoro-2-substituted-1H-benzimidazol-6-yl) morpholine Derivatives. Bioorg. Chem. 2020;101:104002. doi: 10.1016/j.bioorg.2020.104002.", "ArticleIdList": ["10.1016/j.bioorg.2020.104002", "32563964"]}, {"Citation": "El Bakri Y., Anouar E.H., Marmouzi I., Sayah K., Ramli Y., El Abbes Faouzi M., Essassi E.M., Mague J.T. Potential antidiabetic activity and molecular docking studies of novel synthesized benzimidazole and 10-amino-2-methyl-4-oxo pyrimido [1,2-a] benzimidazole derivatives. J. Mol. Model. 2018;24:1\u201310. doi: 10.1007/s00894-018-3705-9.", "ArticleIdList": ["10.1007/s00894-018-3705-9", "29951869"]}, {"Citation": "Aroua L.M., Almuhaylan H.R., Alminderej F.M., Messaoudi S., Chigurupati S., Al-Mahmoud S., Mohammed H.A. A facile approach synthesis of benzoylaryl benzimidazole as potential \u03b1-amylase and \u03b1-glucosidase inhibitor with antioxidant activity. Bioorg. Chem. 2021;114:105073. doi: 10.1016/j.bioorg.2021.105073.", "ArticleIdList": ["10.1016/j.bioorg.2021.105073", "34153810"]}, {"Citation": "Singh G., Singh A., Verma R.K., Mall R., Azeem U. Synthesis, biological evaluation and molecular docking studies of novel benzimidazole derivatives. Comput. Biol. Chem. 2018;72:45\u201352. doi: 10.1016/j.compbiolchem.2017.12.010.", "ArticleIdList": ["10.1016/j.compbiolchem.2017.12.010", "29346072"]}, {"Citation": "Deswal L., Verma V., Kumar D., Kaushik C.P., Kumar A., Deswal Y., Punia S. Synthesis and antidiabetic evaluation of benzimidazole-tethered 1,2,3-triazoles. Arch. Pharm. 2020;353:2000090. doi: 10.1002/ardp.202000090.", "ArticleIdList": ["10.1002/ardp.202000090", "32567729"]}, {"Citation": "G\u00fcnd\u00fcz M.G., Ugur S.B., G\u00fcney F., \u00d6zkul C., Krishna V.S., Kaya S., Sriramd D., Dogan S.D. 1,3-Disubstituted urea derivatives: Synthesis, antimicrobial activity evaluation and in silico studies. Bioorg. Chem. 2020;102:104104. doi: 10.1016/j.bioorg.2020.104104.", "ArticleIdList": ["10.1016/j.bioorg.2020.104104", "32736149"]}, {"Citation": "Ghosh A.K., Brindisi M. Urea derivatives in modern drug discovery and medicinal chemistry. J. Med. Chem. 2019;63:2751\u20132788. doi: 10.1021/acs.jmedchem.9b01541.", "ArticleIdList": ["10.1021/acs.jmedchem.9b01541", "PMC7266097", "31789518"]}, {"Citation": "Mishra C.B., Mongre R.K., Kumari S., Jeong D.K., Tiwari M. Synthesis, in vitro and in vivo anticancer activity of novel 1-(4-imino-1-substituted-1 H-pyrazolo [3,4-d] pyrimidin-5-(4 H)-yl) urea derivatives. RSC Adv. 2016;6:24491\u201324500. doi: 10.1039/C5RA26939C.", "ArticleIdList": ["10.1039/C5RA26939C"]}, {"Citation": "Kilic-Kurt Z., Ozmen N., Bakar-Ates F. Synthesis and anticancer activity of some pyrimidine derivatives with aryl urea moieties as apoptosis-inducing agents. Bioorg. Chem. 2020;101:104028. doi: 10.1016/j.bioorg.2020.104028.", "ArticleIdList": ["10.1016/j.bioorg.2020.104028", "32645482"]}, {"Citation": "Ma L.Y., Wang B., Pang L.P., Zhang M., Wang S.Q., Zheng Y.C., Shao K.P., Xue D.Q., Liu H.M. Design and synthesis of novel 1,2,3-triazole-pyrimidine-urea hybrids as potential anticancer agents. Bioorg. Med. Chem. Lett. 2015;25:1124\u20131128. doi: 10.1016/j.bmcl.2014.12.087.", "ArticleIdList": ["10.1016/j.bmcl.2014.12.087", "25655718"]}, {"Citation": "Faraji A., Motahari R., Hasanvand Z., Bakhshaiesh T.O., Toolabi M., Moghimi S., Firoozpour L., Boshagh M.A., Rahmani R., Ketabforoosh S.H.M.E., et al. Quinazolin-4(3H)-one based agents bearing thiadiazole-urea: Synthesis and evaluation of anti-proliferative and antiangiogenic activity. Bioorg. Chem. 2021;108:104553. doi: 10.1016/j.bioorg.2020.104553.", "ArticleIdList": ["10.1016/j.bioorg.2020.104553", "33376012"]}, {"Citation": "Xie X.X., Li H., Wang J., Mao S., Xin M.H., Lu S.M., Mei Q.B., Zhang S.Q. Synthesis and anticancer effects evaluation of 1-alkyl-3-(6-(2-methoxy-3-sulfonylaminopyridin-5-yl) benzo[d]thiazol-2-yl) urea as anticancer agents with low toxicity. Bioorg. Med. Chem. 2015;23:6477\u20136485. doi: 10.1016/j.bmc.2015.08.013.", "ArticleIdList": ["10.1016/j.bmc.2015.08.013", "26321603"]}, {"Citation": "Ture A., Kahraman D.C., Cetin-Atalay R., Helvacioglu S., Charehsaz M., K\u00fc\u00e7\u00fckg\u00fczel I. Synthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine-(thio) urea hybrids as potential kinase inhibitors. Comput. Biol. Chem. 2019;78:227\u2013241. doi: 10.1016/j.compbiolchem.2018.12.003.", "ArticleIdList": ["10.1016/j.compbiolchem.2018.12.003", "30579980"]}, {"Citation": "Chen J.N., Wang X.F., Li T., Wu D.W., Fu X.B., Zhang G.J., Shen X.C., Wang H.S. Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl urea derivatives as potential anticancer agents. Eur. J. Med. Chem. 2016;107:12\u201325. doi: 10.1016/j.ejmech.2015.10.045.", "ArticleIdList": ["10.1016/j.ejmech.2015.10.045", "26560049"]}, {"Citation": "Kurt B.Z., Kandas N.O., Dag A., Sonmez F., Kucukislamoglu M. Synthesis and biological evaluation of novel coumarin-chalcone derivatives containing urea moiety as potential anticancer agents. Arab. J. Chem. 2020;13:1120\u20131129. doi: 10.1016/j.arabjc.2017.10.001.", "ArticleIdList": ["10.1016/j.arabjc.2017.10.001"]}, {"Citation": "Zarei O., Azimian F., Hamzeh-Mivehroud M., Mojarrad J.S., Hemmati S., Dastmalchi S. Design, synthesis, and biological evaluation of novel benzo[b]thiophene-diaryl urea derivatives as potential anticancer agents. Med. Chem. Res. 2020;29:1438\u20131448. doi: 10.1007/s00044-020-02559-8.", "ArticleIdList": ["10.1007/s00044-020-02559-8"]}, {"Citation": "Aroua L.M., Al-Hakimi A.N., Abdulghani M.A.M., Alhag S.K. Cytotoxic urea Schiff base complexes for multidrug discovery as anticancer activity and low in vivo oral assessing toxicity. Arab. J. Chem. 2022;15:103986. doi: 10.1016/j.arabjc.2022.103986.", "ArticleIdList": ["10.1016/j.arabjc.2022.103986"]}, {"Citation": "Al-Hakimi A.N., Alminderej F., Aroua L., Alhag S.K., Alfaifi M.Y., Mahyoub J.A., Elbehairi S.I., Alnafisah A.S. Design, synthesis, characterization of zirconium (IV), cadmium (II) and iron (III) complexes derived from Schiff base 2-aminomethylbenzimidazole, 2-hydroxynaphtadehyde and evaluation of their biological activity. Arab. J. Chem. 2020;13:7378\u20137389. doi: 10.1016/j.arabjc.2020.08.014.", "ArticleIdList": ["10.1016/j.arabjc.2020.08.014"]}, {"Citation": "Alminderej F.M., Aroua L. Design, Synthesis, Characterization and Anticancer Evaluation of Novel Mixed Complexes Derived from 2-(1H-Benzimizadol-2-yl) aniline Schiff base and 2-Mercaptobenzimidazole or 2-Aminobenzothiazole. Egypt. J. Chem. 2021;64:3351\u20133364. doi: 10.21608/ejchem.2021.60640.3305.", "ArticleIdList": ["10.21608/ejchem.2021.60640.3305"]}, {"Citation": "Aroua L.M., Al-Hakimi A.N., Abdulghani M.A.M., Alhag S.K. Elaboration of novel urea bearing schiff bases as potent in vitro anticancer candidates with low in vivo acute oral toxicity. Main Group Met. Chem. 2022;21:953\u2013973."}, {"Citation": "Ghrab S., Aroua L., Mekni N., Beji M. Simple approach for the regioselective synthesis of a bis (\u03b2-aminoalcohol) derived from polyoxyethylene: First report of fast ring-opening of polyoxyethylene diglycidyl ethers with sodium amide. Res. Chem. Intermed. 2018;44:3537\u20133548. doi: 10.1007/s11164-018-3323-2.", "ArticleIdList": ["10.1007/s11164-018-3323-2"]}, {"Citation": "Ghrab S., Aroua L., Beji M. One-pot Three Component Synthesis of \u03c9-(oxathiolan-2-thion-5-yl)-\u03b1-oxazolidin-2-ones. J. Heterocycl. Chem. 2017;54:2397\u20132404. doi: 10.1002/jhet.2834.", "ArticleIdList": ["10.1002/jhet.2834"]}, {"Citation": "Khan I.A., Saddique F.A., Aslam S., Ashfaq U.A., Ahmad M., Al-Hussain S.A., Zaki M.E.A. Synthesis of Novel N-Methylmorpholine-Substituted Benzimidazolium Salts as Potential \u03b1-Glucosidase Inhibitors. Molecules. 2022;27:6012. doi: 10.3390/molecules27186012.", "ArticleIdList": ["10.3390/molecules27186012", "PMC9501035", "36144750"]}, {"Citation": "Ramasubbu N., Paloth V., Luo Y., Brayer G.D., Levine M.J. Structure of human salivary \u03b1-amylase at 1.6 \u00c5 resolution: Implications for its role in the oral cavity. Acta Crystallogr. Sect. 1996;D52:435\u2013446. doi: 10.1107/S0907444995014119.", "ArticleIdList": ["10.1107/S0907444995014119", "15299664"]}, {"Citation": "Williams L.K., Li C., Withers S.G., Brayer G.D. Order and Disorder: Differential structural impacts of myricetin and ethyl caffeate on human amylase, an antidiabetic target. J. Med. Chem. 2012;55:10177\u201310186.", "ArticleIdList": ["23050660"]}, {"Citation": "Roig-Zamboni V., Cobucci-Ponzano B., Iacono R., Ferrara M.C., Germany S., Bourne Y., Parenti G., Moracci M., Sulzenbacher G. Structure of human lysosomal acid \u03b1-glucosidase\u2013a guide for the treatment of Pompe disease. Nat. Commun. 2017;8:1111. doi: 10.1038/s41467-017-01263-3.", "ArticleIdList": ["10.1038/s41467-017-01263-3", "PMC5653652", "29061980"]}, {"Citation": "Mohammed H.A., Al-Omar M.S., Khan R.A., Mohammed S.A.A., Qureshi K.A., Abbas M.M., Al Rugaie O., Abd-Elmoniem E., Ahmad A.M., Kandil Y.I. Chemical Profile, Antioxidant, Antimicrobial, and Anticancer Activities of the Water-Ethanol Extract of Pulicaria Undulata Growing in the Oasis of Central Saudi Arabian Desert. Plants. 2021;10:1811. doi: 10.3390/plants10091811.", "ArticleIdList": ["10.3390/plants10091811", "PMC8472717", "34579344"]}, {"Citation": "Benzie I.F.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: The FRAP assay. Anal. Biochem. 1996;239:70\u201376. doi: 10.1006/abio.1996.0292.", "ArticleIdList": ["10.1006/abio.1996.0292", "8660627"]}, {"Citation": "Mohammed H.A. Phytochemical Analysis, Antioxidant Potential, and Cytotoxicity Evaluation of Traditionally Used Artemisia Absinthium L. (Wormwood) Growing in the Central Region of Saudi Arabia. Plants. 2022;11:1028. doi: 10.3390/plants11081028.", "ArticleIdList": ["10.3390/plants11081028", "PMC9029736", "35448756"]}, {"Citation": "Martin A.E., Montgomery P.A. Acarbose: An Alpha-Glucosidase Inhibitor. Am. J. Health-Syst. Pharm. 1996;53:2277\u20132290. doi: 10.1093/ajhp/53.19.2277.", "ArticleIdList": ["10.1093/ajhp/53.19.2277", "8893066"]}, {"Citation": "Yousuf S., Khan K.M., Salar U., Chigurupati S., Muhammad M.T., Wadood A., Aldubayan M., Vijayan V., Riaz M., Perveen S. 2\u2032-Aryl and 4\u2032-arylidene substituted pyrazolones: As potential \u03b1-amylase inhibitors. Eur. J. Med. Chem. 2018;159:47\u201358. doi: 10.1016/j.ejmech.2018.09.052.", "ArticleIdList": ["10.1016/j.ejmech.2018.09.052", "30268823"]}, {"Citation": "Saleem F., Khan K.M., Chigurupati S., Solangi M., Nemala A.R., Mushtaq M., Ul-Haq Z., Taha M., Perveen S. Synthesis of azachalcones, their \u03b1-amylase, \u03b1-glucosidase inhibitory activities, kinetics, and molecular docking studies. Bioorg. Chem. 2021;106:104489. doi: 10.1016/j.bioorg.2020.104489.", "ArticleIdList": ["10.1016/j.bioorg.2020.104489", "33272713"]}, {"Citation": "Morris G.M., Huey R., Olson A.J. Using AutoDock for ligand-receptor docking. Curr. Protoc. Bioinform. 2008;24:8\u201314. doi: 10.1002/0471250953.bi0814s24.", "ArticleIdList": ["10.1002/0471250953.bi0814s24", "19085980"]}, {"Citation": "Mseddi K., Alimi F., Noumi E., Veettil V.N., Deshpande S., Adnan M., Hamdi A., Elkahoui S., Ahmed A., Kadri A., et al. Thymus musilii Velen. as a promising source of potent bioactive compounds with its pharmacological properties: In vitro and in silico analysis. Arab. J. Chem. 2020;13:6782\u20136801."}, {"Citation": "Pedretti A., Villa L., Vistoli G. VEGA-An open platform to develop chemo-bioinformatics applications, using plug-in architecture and script programming. J. Comput. Aided Mol. Des. 2004;18:167\u2013173. doi: 10.1023/B:JCAM.0000035186.90683.f2.", "ArticleIdList": ["10.1023/B:JCAM.0000035186.90683.f2", "15368917"]}, {"Citation": "Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Dassault Systems BIOVIA . BIOVIA Discovery Studio Visualizer. Dassault Systems; San Diego, CA, USA: 2015. v16.1.0.15350."}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "19"}, {"Year": "2023", "Month": "1", "Day": "24"}, {"Year": "2023", "Month": "1", "Day": "26"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "4", "Minute": "17"}, {"Year": "2023", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "26", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "1", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["36839780", "PMC9963656", "10.3390/pharmaceutics15020457", "pharmaceutics15020457"]}}], "PubmedBookArticle": []}